Wall Street analysts forecast that RTI Surgical, Inc. (NASDAQ:RTIX) will announce $0.02 earnings per share (EPS) for the current quarter, according to Zacks. Two analysts have made estimates for RTI Surgical’s earnings. RTI Surgical posted earnings per share of $0.01 during the same quarter last year, which would indicate a positive year-over-year growth rate of 100%. The company is expected to issue its next quarterly earnings report on Thursday, February 22nd.

On average, analysts expect that RTI Surgical will report full year earnings of $0.05 per share for the current fiscal year, with EPS estimates ranging from $0.04 to $0.05. For the next fiscal year, analysts expect that the firm will post earnings of $0.14 per share, with EPS estimates ranging from $0.10 to $0.19. Zacks Investment Research’s EPS calculations are a mean average based on a survey of analysts that that provide coverage for RTI Surgical.

RTI Surgical (NASDAQ:RTIX) last issued its quarterly earnings data on Thursday, November 2nd. The medical equipment provider reported $0.01 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.01. RTI Surgical had a net margin of 1.01% and a return on equity of 2.35%. The firm had revenue of $66.69 million during the quarter, compared to the consensus estimate of $65.63 million. The business’s revenue was up .2% on a year-over-year basis.

A number of equities research analysts have recently issued reports on RTIX shares. BidaskClub downgraded shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Zacks Investment Research raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a research report on Friday, October 13th.

In other news, Director Nicholas J. Valeriani acquired 5,500 shares of RTI Surgical stock in a transaction that occurred on Monday, August 21st. The shares were bought at an average cost of $4.70 per share, with a total value of $25,850.00. Following the transaction, the director now directly owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John N. Varela acquired 12,000 shares of RTI Surgical stock in a transaction that occurred on Friday, August 11th. The stock was purchased at an average cost of $4.85 per share, for a total transaction of $58,200.00. Following the completion of the transaction, the executive vice president now directly owns 47,998 shares in the company, valued at $232,790.30. The disclosure for this purchase can be found here. 4.90% of the stock is owned by insiders.

A number of institutional investors have recently bought and sold shares of the stock. Prudential Financial Inc. purchased a new stake in RTI Surgical in the 3rd quarter worth about $111,000. Strs Ohio raised its position in RTI Surgical by 19.5% in the 3rd quarter. Strs Ohio now owns 142,300 shares of the medical equipment provider’s stock worth $647,000 after purchasing an additional 23,200 shares during the period. Rutabaga Capital Management LLC MA bought a new position in RTI Surgical in the 2nd quarter worth about $4,939,000. State Street Corp grew its stake in RTI Surgical by 10.4% in the 2nd quarter. State Street Corp now owns 1,123,603 shares of the medical equipment provider’s stock worth $6,577,000 after acquiring an additional 106,204 shares in the last quarter. Finally, Goldman Sachs Group Inc. grew its stake in RTI Surgical by 2.1% in the 2nd quarter. Goldman Sachs Group Inc. now owns 87,767 shares of the medical equipment provider’s stock worth $513,000 after acquiring an additional 1,782 shares in the last quarter. 70.03% of the stock is currently owned by institutional investors.

ILLEGAL ACTIVITY NOTICE: “Brokerages Anticipate RTI Surgical, Inc. (RTIX) Will Post Earnings of $0.02 Per Share” was published by American Banking News and is owned by of American Banking News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark law. The correct version of this news story can be viewed at https://www.americanbankingnews.com/2017/11/04/brokerages-anticipate-rti-surgical-inc-rtix-will-post-earnings-of-0-02-per-share.html.

Shares of RTI Surgical (NASDAQ RTIX) traded up $0.10 during mid-day trading on Friday, hitting $4.80. 242,515 shares of the stock were exchanged, compared to its average volume of 148,338. RTI Surgical has a 12-month low of $2.50 and a 12-month high of $6.00. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 3.00. The company has a market cap of $285.64, a P/E ratio of 120.00, a price-to-earnings-growth ratio of 5.82 and a beta of 1.73.

RTI Surgical Company Profile

RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.

Get a free copy of the Zacks research report on RTI Surgical (RTIX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.